Drug General Information
Drug ID
D0J0EM
Former ID
DIB003170
Drug Name
Virexxa
Indication Endometrial cancer [ICD9: 182; ICD10:C54.1] Phase 2 [524647]
Company
Pharmsynthez ZAO
Target and Pathway
Target(s) Progesterone receptor Target Info Inducer [543903]
KEGG Pathway Oocyte meiosis
Progesterone-mediated oocyte maturation
Pathway Interaction Database Cellular roles of Anthrax toxin
Reactome Nuclear signaling by ERBB4
Nuclear Receptor transcription pathway
WikiPathways Ovarian Infertility Genes
Signaling by ERBB4
Nuclear Receptors
References
Ref 524647ClinicalTrials.gov (NCT02064725) Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA. U.S. National Institutes of Health.
Ref 543903(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 627).

If you find any error in data or bug in web service, please kindly report it to Dr. Wang and Dr. Li.